Stock Events

Stock Events

Werewolf Therapeutics 

$0.8363
45
-$0.04-4.26% 09:42 Today

Statistics

Day High
0.8991
Day Low
0.872
52W High
2.19
52W Low
0.308
Volume
703,361
Avg. Volume
-
Mkt Cap
42.45M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.47
-0.29
-0.1
0.08
Expected EPS
-0.22
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-60.82MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HOWL. It's not an investment recommendation.
NVIDIA
7
NVDA
Tesla
6
TSLA
Apple
4
AAPL
Realty Income
4
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bristol-Myers Squibb
BMY
Mkt Cap136.88B
Bristol Myers Squibb is a leading biopharmaceutical company that competes in the oncology space, directly challenging Werewolf Therapeutics' cancer immunotherapy approaches.
Merck
MRK
Mkt Cap376.37B
Merck & Co., Inc. is a global healthcare company that develops immunotherapy treatments for cancer, competing with Werewolf Therapeutics' innovative therapies.
Gilead Sciences
GILD
Mkt Cap181.18B
Gilead Sciences, Inc. focuses on the development of drugs for cancer treatment, making it a competitor in the oncology market alongside Werewolf Therapeutics.
AMGEN
AMGN
Mkt Cap237.52B
Amgen Inc. is a biotechnology company engaged in the discovery of novel cancer treatments, competing with Werewolf Therapeutics in the biopharmaceutical sector.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.87B
Regeneron Pharmaceuticals, Inc. is involved in the development of cancer immunotherapies, directly competing with Werewolf Therapeutics' focus on modulating the immune system to fight cancer.
Novartis
NVS
Mkt Cap301.95B
Novartis AG is a healthcare company that offers a range of cancer treatments, including immunotherapies that compete with Werewolf Therapeutics' product pipeline.
Pfizer
PFE
Mkt Cap159.99B
Pfizer Inc. is a global pharmaceutical corporation with a strong presence in the oncology market, making it a competitor to Werewolf Therapeutics.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a major player in the development of cancer treatments, including immunotherapies that rival Werewolf Therapeutics' approaches.
Astrazeneca
AZN
Mkt Cap257.42B
AstraZeneca PLC is a biopharmaceutical company focusing on the development of cancer therapies, competing with Werewolf Therapeutics in the oncology sector.
Johnson & Johnson
JNJ
Mkt Cap651.25B
Johnson & Johnson is a diversified healthcare company that develops and markets cancer treatments, competing with Werewolf Therapeutics in the pharmaceutical and biotechnology industry.

About

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
Show more...
CEO
Daniel J. Hicklin
Employees
14
Country
United States
ISIN
US95075A1079

Listings

XNAS
US
HOWL
BOATS
BOATS
HOWL.BOATS

0 Comments

Share your thoughts

FAQ

What is Werewolf Therapeutics stock price today?▼
The current price of HOWL is $0.84 USD — it has decreased by -4.26% in the past 24 hours. Watch Werewolf Therapeutics stock price performance more closely on the chart.
What is Werewolf Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Werewolf Therapeutics stocks are traded under the ticker HOWL.
Is Werewolf Therapeutics stock price growing?▼
HOWL stock has risen by +115.15% compared to the previous week, the month change is a +104.57% rise, over the last year Werewolf Therapeutics has showed a -33.83% decrease.
What is Werewolf Therapeutics market cap?▼
Today Werewolf Therapeutics has the market capitalization of 42.45M
When is the next Werewolf Therapeutics earnings date?▼
Werewolf Therapeutics is going to release the next earnings report on November 05, 2026.
What were Werewolf Therapeutics earnings last quarter?▼
HOWL earnings for the last quarter are 0.08 USD per share, whereas the estimation was -0.28 USD resulting in a +128.57% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Werewolf Therapeutics revenue for the last year?▼
Werewolf Therapeutics revenue for the last year amounts to 0 USD.
What is Werewolf Therapeutics net income for the last year?▼
HOWL net income for the last year is -60.82M USD.
How many employees does Werewolf Therapeutics have?▼
As of August 24, 2026, the company has 14 employees.
In which sector is Werewolf Therapeutics located?▼
Werewolf Therapeutics operates in the Health & Wellness sector.
When did Werewolf Therapeutics complete a stock split?▼
Werewolf Therapeutics has not had any recent stock splits.
Where is Werewolf Therapeutics headquartered?▼
Werewolf Therapeutics is headquartered in WATERTOWN, United States.